364 filings
Page 4 of 19
DEF 14C
MDIT
Medite Cancer Diagnostics, Inc.
11 Aug 17
Information statement
12:00am
PRE 14C
MDIT
Medite Cancer Diagnostics, Inc.
1 Aug 17
Preliminary information
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
12 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
6 Jun 17
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
10-Q
2017 Q1
MDIT
Medite Cancer Diagnostics, Inc.
Quarterly report
15 May 17
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
10 May 17
Departure of Directors or Certain Officers
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
27 Apr 17
MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer
12:00am
10-K
2016 FY
MDIT
Medite Cancer Diagnostics, Inc.
Annual report
14 Apr 17
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
4 Apr 17
Entry into a Material Definitive Agreement
12:00am
NT 10-K
MDIT
Medite Cancer Diagnostics, Inc.
30 Mar 17
Notice of late annual filing
12:00am
DEF 14C
MDIT
Medite Cancer Diagnostics, Inc.
21 Mar 17
Information statement
12:00am
3
Eric Michael Goehausen
21 Mar 17
Medite Cancer Diagnostics / Eric Michael Goehausen ownership change
12:00am
PRE 14C
MDIT
Medite Cancer Diagnostics, Inc.
10 Mar 17
Preliminary information
12:00am
D
MDIT
Medite Cancer Diagnostics, Inc.
9 Mar 17
$4.25M in equity / options, sold $555K, 8 investors
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
23 Feb 17
Departure of Directors or Certain Officers
12:00am
D
MDIT
Medite Cancer Diagnostics, Inc.
9 Feb 17
$3M in equity / options, sold $411.92K, 5 investors
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
18 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
MDIT
Medite Cancer Diagnostics, Inc.
11 Jan 17
Changes in Registrant's Certifying Accountant
12:00am